Tactics for Choosing Optimal Parameters of Intense Pulsed Light in Treatment of Erythematotelangiectatic Subtype of Rosacea

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

INTRODUCTION: There exist several approaches to treatment of rosacea: systemic, external or complex therapy. Many practitioners note the effectiveness of using intense pulsed light in treatment of rosacea acne. Along with hardware techniques, azelaic acid-based gel is actively used in treatment. Despite the growing popularity of phototherapy, there is insufficient scientific literature on the study of optimal parameters of intense pulsed light for patients using azelaic acid.

AIM: To describe the experience of application of a combination of intense pulsed light and azelaic acid in erythematotelangiectatic subtype of rosacea.

A clinical case of a 52-year-old female patient with severe erythematotelangiectatic rosacea. Phototherapy was conducted in a course of 7 procedures with an interval of 3 weeks; azelaic-based gel was prescribed twice a day for 5 months, sunscreen cream with protection factor 50 for daily use. For the first procedure, a filter with 640 nm wave length was used, fluence 22 J/cm2, pulse duration 3.5 ms, number of subpulses — 3; filter with 590 n wavelength, fluence 22 J/cm2, pulse duration 3.5 ms, number of subpulses — 3; filter with 560 nm wavelength, fluence 20 J/cm2, pulse duration 3.5 ms, number of subpulses — 3; filter with 515 nm wavelength, fluence 16 J/cm2, pulse duration 3.5 ms, number of subpulses — 3. After 3 weeks, a second phototherapy procedure was conducted according to the same protocol. In the third procedure, the energy flow on each filter was increased by 1 J, pulse duration and number of subpulses did not change. On examination in 3 weeks, there was a reduction of the number of small and large telangiectasias, significant reduction of redness, no disturbing subjective sensations. In the subsequent procedures it was decided not to increase the energy flow on filters to avoid recurrent undesired phenomena.

CONCLUSION: Clinical observation demonstrated the effectiveness of using a combination of intense pulsed light and azelaic acid in erythematotelangiectatic rosacea when selecting the maximum permissible parameters of phototherapy. When treating with intense pulsed light it is permissible to increase the energy flow by 1 J/cm2–2 J/cm2 on condition of normal tolerance. In case edema and hyperemia are present for more than 3 days, it is necessary to reduce the energy flow.

全文:

受限制的访问

作者简介

Elena Zhil'tsova

Ryazan State Medical University

Email: elen_egorovna@mail.ru
ORCID iD: 0000-0001-9406-6841
SPIN 代码: 5688-0672

MD, Dr. Sci. (Med.), Associate Professor

俄罗斯联邦, Ryazan

Kseniya Mezhevaya

Beauty Institute «LETE»

编辑信件的主要联系方式.
Email: ks_andreeva@hotmail.com
ORCID iD: 0000-0002-4096-1338
俄罗斯联邦, Ryazan

参考

  1. Kubanova AA, Makhakova YuB. Rosacea: prevalence, pathogenesis, particular features of clinical manifestations. Vestnik Dermatologii i Venerologii. 2015;(3):36–45. (In Russ).
  2. Kubanova AA, Makhakova YuB. Rosacea: diagnostics and treatment. Vestnik Dermatologii i Venerologii. 2015;(4):27–35. (In Russ).
  3. Wollina U. Is rosacea a systemic disease? Clin Dermatol. 2019;37(6):629–35. doi: 10.1016/j.clindermatol.2019.07.032
  4. Yusupovа LA, Yunusovа EI, Garaeva ZSh, et al. Clinical variations and therapy of patients with rosacea. Lechaschi Vrach. 2019;(6):77–9. (In Russ.)
  5. Forton FMN. The pathogenic role of demodex mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea? Dermatol Ther (Heidelb). 2020;10(6):1229–53. doi: 10.1007/s13555-020-00458-9
  6. Barakji YA, Rønnstad ATM, Christensen MO, et al. Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea: A Systematic Review and Meta-analysis. JAMA Dermatol. 2022;158(6):617–25. doi: 10.1001/jamadermatol.2022.0526
  7. Vorozheykin PYu. Vzglyad dermatovenerologa na sovremennyye aspekty etiopatogeneza rozatsea. Metamorfozy. 2019;(25):26–8. (In Russ).
  8. Samtsov AV. Evolyutsiya predstavleniy o rozatsea. Opinion Leader. 2020;(10):52–8. (In Russ).
  9. Babadzhanov OA, Arifov SS. The role of TNF-À in the formation of rosacea. Medicinskie Novosti. 2020;(3):73–5. (In Russ).
  10. Snarskaya ES, Rusina TS. Modern concepts of erythemato-telangiectatic rosacea pathogenesis and treatment. Russian Journal of Skin and Venereal Diseases. 2021;24(4):367–74. (In Russ). doi: 10.17816/dv87993
  11. Shakirova AT. Psychoemotional states and compliance in the treatment of rosacea. Zdravookhraneniye Kyrgyzstana. 2019;(4):114–6. (In Russ).
  12. Zhiltsova EE, Mezhevaya KV. Evaluation of Effect of Therapy with Intensive Pulsed Light on Psychoemotional State of Patients with Erythematotelangiectatic Rosacea. I. P. Pavlov Russian Medical Biological Herald. 2024;32(1):103–10. (In Russ). doi: 10.17816/PAVLOVJ342053
  13. Baldwin BHE, Harper J, Baradaran S, et al. Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society. Dermatol Ther (Heidelb). 2019;9(4):725–34. doi: 10.1007/s13555-019-00322-5
  14. Denysenko OI, Storozhuk MV. Comprehensive treatment of rosacea patients taking into account the indicators of inflammatory mediators and the state of prooxidant–antioxidant homeostasis. Dermatology. Cosmetology. Sexopathology. 2019;(3–4):26–37. (In Russ).
  15. Bilalova KA, Yusupova LA. Rosacea: features of pathogenesis and therapy. European Journal of Natural History. 2022;(2):18–21. doi: 10.17513/ejnh.34252
  16. De Oliveira CMM, Almeida LMC, Bonamigo RR, et al. Consensus on the therapeutic management of rosacea — Brazilian Society of Dermatology. An Bras Dermatol. 2020;95(Suppl 1):53–69. doi: 10.1016/j.abd.2020.08.001
  17. Butov YuS, Skripkin YuK, Ivanov OL, editors. Dermatovenerologiya. Natsional'noye rukovodstvo. Kratkoye izdaniye. Moscow: GEOTAR-Media; 2017. P. 669–80. (In Russ).
  18. Kokina OA, Zakora VE. Vozmozhnosti IPL-terapii v lechenii rozatsea. Scientist (Russia). 2019;(3):16. (In Russ).
  19. Gaydina TA, Skripkina PA, Galayda AO, et al. Application of intensive light radiation in the patient with erythematotelangiectatic rosacea. The Russian Archives of Internal Medicine. 2018;8(1):71–6. (In Russ). doi: 10.20514/2226-6704-2018-8-1-71-76
  20. Urakova DS. Primeneniye svetovykh tekhnologiy v terapii rozatsea. Dermatology in Russia. 2018;(S1):164–6. (In Russ).
  21. Bharty J, Sonthalia S, Jakhar D. Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea. J Am Acad Dermatol. 2023;88(6):e295–6. doi: 10.1016/j.jaad.2018.05.014
  22. Choi JE, Werbel T, Wang Z, et al. Botulinum toxin blocks mast cell sand prevents rosacea like inflammation. J Dermatol Sci. 2019;93(1):58–64. doi: 10.1016/j.jdermsci.2018.12.004
  23. Ravlyuk DA, Pritulo OA, Prokhorov DV, et al. Opportunities and perspectives for application of abobotulotoxin A in skin diseases. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2019;22(4):96–100. (In Russ).
  24. Zhiltsova EE, Chakhoyan LR, Konovalov OE, et al. Medical and social characteristics and medical activity of patients with neuro-allergic diseases. Nauka Molodykh (Eruditio Juvenium). 2019;7(4):526–32. (In Russ). doi: 10.23888/HMJ201974526-532

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Objective status of the skin of patient N., 52 years old, before the first procedure (a) and after a course of procedures (b).

下载 (61KB)
索引源数据
3. Fig. 2. Dermatoscopic picture of skin ofthe cheek-zygomatic area of patient N., 52 years old, before the first procedure (a) and after a course of procedures (b).

下载 (34KB)
索引源数据

版权所有 © Eco-Vector, 2024


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



##common.cookie##